VIA
CVS icon

Vantage Investment Advisors’s CVS Health CVS Stock Holding History

Vantage Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$130K Buy
2,000
+350
+21% +$25K 0.03% 190
2018
Q2 		$106K Sell
1,650
-100
-6% -$6.59K 0.03% 199
2018
Q1 		$109K Sell
1,750
-860
-33% -$61.7K 0.03% 187
2017
Q4 		$189K Hold
2,610
– – 0.04% 154
2017
Q3 		$212K Hold
2,610
– – 0.05% 130
2017
Q2 		$210K Sell
2,610
-6,517
-71% -$515K 0.06% 127
2017
Q1 		$716K Sell
9,127
-3,469
-28% -$277K 0.24% 69
2016
Q4 		$994K Sell
12,596
-48,872
-80% -$3.95M 0.4% 55
2016
Q3 		$5.47M Sell
61,468
-1,165
-2% -$110K 2.43% 9
2016
Q2 		$6M Buy
62,633
+2,175
+4% +$217K 2.52% 9
2016
Q1 		$6.27M Buy
60,458
+5,568
+10% +$541K 2.77% 9
2015
Q4 		$5.37M Buy
54,890
+2,164
+4% +$212K 2.7% 9
2015
Q3 		$5.09M Buy
52,726
+1,950
+4% +$205K 2.87% 8
2015
Q2 		$5.33M Sell
50,776
-44,141
-47% -$4.51M 2.94% 7
2015
Q1 		$9.8M Buy
94,917
+43,859
+86% +$4.44M 2.78% 6
2014
Q4 		$4.92M Buy
51,058
+460
+0.9% +$40.5K 2.78% 8
2014
Q3 		$4.03M Buy
50,598
+1,269
+3% +$100K 2.44% 8
2014
Q2 		$3.72M Buy
49,329
+997
+2% +$75.3K 2.28% 10
2014
Q1 		$3.62M Buy
48,332
+581
+1% +$41K 2.39% 8
2013
Q4 		$3.42M Buy
+47,751
New +$3.07M 2.33% 10

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vantage Investment Advisors's CVS Position: Q3 2018 in Review

Vantage Investment Advisors increased its CVS Health (CVS) stake by 21% in Q3 2018, buying an estimated $25K and bringing the position to 2,000 shares worth $130K. The position accounts for 0.03% of the portfolio, ranked #190.

Vantage Investment Advisors first reported a position in CVS in Q4 2013 and has held it in 20 quarters since. The position peaked at $9.8M in Q1 2015. 1,599 funds tracked by Wall St. Rank hold CVS as of Q3 2018.

  • Vantage Investment Advisors held 2,000 shares of CVS Health worth $130K as of Q3 2018.
  • Vantage Investment Advisors bought 350 CVS Health shares in Q3 2018, an estimated $25K.
  • CVS Health made up 0.03% of Vantage Investment Advisors's portfolio in Q3 2018, its #190 holding.
  • Vantage Investment Advisors first reported a position in CVS Health in Q4 2013 and has held it in 20 quarters since.
  • Vantage Investment Advisors's CVS Health position peaked at $9.8M in Q1 2015.
  • 1,599 funds tracked by Wall St. Rank held CVS Health as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.